美国药品NDC（国家药品编码）与药品说明书数据库（U.S. FDA National Drug Code DataBase）

NDC包装代码	产品NDC	产品类型	商品名	通用名	剂型	给药途径	上市日期	结束日期	市场类别	申请号	标签持有者	活性成分	规格	包装描述
29033-058-01	29033-058	HUMAN PRESCRIPTION DRUG	Theophylline	Theophylline	TABLET, EXTENDED RELEASE	ORAL	20230816	N/A	ANDA	ANDA087400	Nostrum Laboratories, Inc.	THEOPHYLLINE ANHYDROUS	200 mg/1	100 TABLET, EXTENDED RELEASE in 1 BOTTLE (29033-058-01)
71321-501-10	71321-501	HUMAN PRESCRIPTION DRUG	Theophylline	Theophylline	TABLET, EXTENDED RELEASE	ORAL	20250930	N/A	ANDA	ANDA087400	Brandywine Pharmaceuticals, LLC	THEOPHYLLINE ANHYDROUS	200 mg/1	100 TABLET, EXTENDED RELEASE in 1 BOTTLE (71321-501-10)
71321-502-10	71321-502	HUMAN PRESCRIPTION DRUG	Theophylline	Theophylline	TABLET, EXTENDED RELEASE	ORAL	20250930	N/A	ANDA	ANDA087400	Brandywine Pharmaceuticals, LLC	THEOPHYLLINE ANHYDROUS	300 mg/1	100 TABLET, EXTENDED RELEASE in 1 BOTTLE (71321-502-10)
29033-057-01	29033-057	HUMAN PRESCRIPTION DRUG	Theophylline	Theophylline	TABLET, EXTENDED RELEASE	ORAL	20230816	N/A	ANDA	ANDA087400	Nostrum Laboratories, Inc.	THEOPHYLLINE ANHYDROUS	100 mg/1	100 TABLET, EXTENDED RELEASE in 1 BOTTLE (29033-057-01)
71321-500-10	71321-500	HUMAN PRESCRIPTION DRUG	Theophylline	Theophylline	TABLET, EXTENDED RELEASE	ORAL	20250930	N/A	ANDA	ANDA087400	Brandywine Pharmaceuticals, LLC	THEOPHYLLINE ANHYDROUS	100 mg/1	100 TABLET, EXTENDED RELEASE in 1 BOTTLE (71321-500-10)
29033-059-01	29033-059	HUMAN PRESCRIPTION DRUG	Theophylline	Theophylline	TABLET, EXTENDED RELEASE	ORAL	20230816	N/A	ANDA	ANDA087400	Nostrum Laboratories, Inc.	THEOPHYLLINE ANHYDROUS	300 mg/1	100 TABLET, EXTENDED RELEASE in 1 BOTTLE (29033-059-01)